NASDAQ:KYMR

Kymera Therapeutics Earning Date

USA |NASDAQ |USD

KYMR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.42 $-0.55 $-0.39
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $19.61M $18.52M $14.53M

Kymera Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

KYMR Earnings Date & History Chart

KYMR Earnings & Revenue Forecast

KYMR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.43 $-0.67 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.73 $-2.13 $-1.19
Dec 2022 10 $-2.15 $-3.56 $-0.46

KYMR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.39 $-0.39 $-0.18
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.63 $-1.63 $-1.21
Dec 2022 0 / 0 $-2.11 $-2.11 $-1.59

KYMR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $20.84M $15.00M $29.28M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $77.37M $67.20M $90.00M
Dec 2022 10 $80.15M $30.00M $140.00M

KYMR Earnings Date & Revenue History

KYMR Earnings History

|
Show More
Show More

KYMR Revenue History

|
Show More
Show More

Kymera Therapeutics Next Earnings Date & Report

KYMR Next Earnings Date & Report Preview: Sep 2021 (FQ)

KYMR's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Kymera Therapeutics's next quarterly earnings is $-0.42, with a low EPS estimation of $-0.59, and a high estimation of $-0.22.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.40, the last 2 month trend is $-0.40, and the 3 month trend is $-0.21.

Based on 6 analysts, the average revenue estimation is $19.61M, with a low revenue estimation of $15.00M, and a high estimation of $25.00M.

Kymera Therapeutics Previous Earnings Dates & Reports

KYMR Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Kymera Therapeutics's previous earnings date was Aug 6, 2021 for its fiscal quarter ended Jun 30, 2021.

KYMR's earnings per share (EPS) was $-0.55, missing the consensus analysts forecast of $-0.25 by -122.40%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 89.66%.

Revenues were $18.52M, better than the forecast of $18.52M by 0.00%, down by -0.98% from the previous quarter , and up by 463.23% from the same period last year.

The company reported a net income of $-24.66M.

Free cash flow for the quarter was $-31.14M , compared to $-22.99M last quarter and $-15.27M a year before.

KYMR ended the quarter with $18.30M in total debt, an increase of 4.77% compared to the previous quarter, and a decrease of -4.19% compared to the same quarter a year before.

KYMR Previous Earnings Date & Report Recap: Dec 2020 (FY)

Kymera Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

KYMR's earnings per share (EPS) was $-0.68.

Revenues were $34.03M, worse than the forecast of $42.02M by -19.01%, and up by 1059.99% from previous year's revenue.

The company reported a net income of $-45.59M.

Kymera Therapeutics reported a free cash flow of $79.03M for its fiscal year, compared to $17.37M a year ago.

The company ended the fiscal year with $17.99M in total debt, a decrease of -15.10% compared to the previous year.